Document:

Exhibit 4.4

 

WARRANT AGREEMENT

 

This
agreement is made as of _____, 2021 between Northern Genesis Acquisition Corp. II, a Delaware corporation, with offices at 4801
Main Street, Suite 1000, Kansas City, MO 64112 (“Company”), and Continental Stock Transfer & Trust Company,
a New York corporation, with offices at 1 State Street, New York, New York 10004 (“Warrant Agent”).

 

WHEREAS,
the Company is engaged in a public offering (“Public Offering”) of up to 34,500,000 units, each such unit (a
“Public Unit”) comprised of one share of common stock of the Company, par value $.0001 per share (“Common
Stock”), and one-third of one warrant, where each whole warrant entitles the holder to purchase one share of Common Stock
at a price of $11.50 per share, subject to adjustment as described herein, and, in connection therewith, will issue and deliver
up to 11,500,000 warrants (the “Public Warrants”) to the public investors in connection with the Public Offering;
and

 

WHEREAS,
the Company has filed with the Securities and Exchange Commission (the “SEC”) a Registration Statement on Form
S-1, No. 333-251639 (“Registration Statement”), for the registration, under the Securities Act of 1933, as amended
(“Act”) of, among other securities, the Public Warrants; and

 

WHEREAS,
the Company has received a binding commitment (the “Subscription Agreement”) from Northern Genesis Sponsor II
LLC to purchase up to an aggregate of 5,766,667 Warrants (the “Private Placement Warrants”) upon consummation
of the Public Offering; and

 

WHEREAS,
the Company may issue up to an additional 2,000,000 Warrants (“Working Capital Warrants”) in satisfaction of
certain working capital loans made by the Company’s officers, directors, initial stockholders and affiliates;

 

WHEREAS,
the Company have entered into agreement with Northern Genesis Capital LLC pursuant to which the Company may issue units (“Forward
Purchase Units”) comprised of one share of Common Stock and one-sixth of one warrant, where each whole warrant entitles
the holder to purchase one share of Common Stock at a price of $11.50 per share, subject to adjustment as described herein (the
“Forward Purchase Warrants”); and

 

WHEREAS,
following consummation of the Public Offering, the Company may issue additional warrants (“Post IPO Warrants”
and together with the Public Warrants, Private Placement Warrants, and Working Capital Warrants, the “Warrants”)
in connection with, or following the consummation by the Company of, a Business Combination (defined below); and

 

WHEREAS,
the Company desires the Warrant Agent to act on behalf of the Company, and the Warrant Agent is willing to so act, in connection
with the issuance, registration, transfer, exchange, redemption, and exercise of the Warrants; and

 

     

     

    

 

WHEREAS,
the Company desires to provide for the form and provisions of the Warrants, the terms upon which they shall be issued and exercised,
and the respective rights, limitation of rights, and immunities of the Company, the Warrant Agent, and the holders of the Warrants;
and

 

WHEREAS,
all acts and things have been done and performed which are necessary to make the Warrants, when executed on behalf of the
Company and countersigned by or on behalf of the Warrant Agent (if a physical certificate is issued), as provided herein, the valid, binding, and legal
obligations of the Company, and to authorize the execution and delivery of this Agreement.

 

NOW,
THEREFORE, in consideration of the mutual agreements herein contained, the parties hereto agree as follows:

 

1. Appointment
of Warrant Agent. The Company hereby appoints the Warrant Agent to act as agent for the Company for the Warrants, and the Warrant
Agent hereby accepts such appointment and agrees to perform the same in accordance with the terms and conditions set forth in this
Agreement.

 

2. Warrants.

 

2.1. Form
of Warrant. Each Warrant shall be issued in registered form only, shall be in substantially the form of Exhibit A hereto, the
provisions of which are incorporated herein and shall be signed by, or bear the facsimile signature of, the Board Chair, Chief
Executive Officer or President of the Company and the Chief Financial Officer, Treasurer, Secretary or Assistant Secretary of the
Company and shall bear a facsimile of the Company’s seal. In the event the person whose facsimile signature has been placed
upon any Warrant shall have ceased to serve in the capacity in which such person signed the Warrant before such Warrant is issued,
it may be issued with the same effect as if he or she had not ceased to be such at the date of issuance.

 

2.2. Uncertificated
Warrants. Notwithstanding anything herein to the contrary, (a) any Warrant, or portion thereof, may be issued as part of, and
be represented by, bundled security consisting of one or more full or partial shares of Common Stock and one or more full or partial
Warrants (a “Unit”), and (b) any Warrant may be issued in uncertificated or book-entry form through the Warrant
Agent and/or the facilities of The Depository Trust Company (the “Depositary”) or other book-entry depositary
system, in each case as determined by the Board of Directors of the Company or by an authorized committee thereof. Any Warrant
so issued shall have the same terms, force and effect as a certificated Warrant that has been duly countersigned by the Warrant
Agent in accordance with the terms of this Agreement.

 

2.3. Effect
of Countersignature. Except with respect to uncertificated Warrants as described above, unless and until countersigned by the
Warrant Agent pursuant to this Agreement, a Warrant shall be invalid and of no effect and may not be exercised by the holder thereof.

 

    2

     

    

 

2.4. Registration.

 

2.4.1.
Warrant Register. The Warrant Agent shall maintain books (“Warrant Register”) for the registration of
original issuance and the registration of transfer of the Warrants. Upon the initial issuance of the Warrants, the Warrant Agent
shall issue and register the Warrants in the names of the respective holders thereof in such denominations and otherwise in accordance
with instructions delivered to the Warrant Agent by the Company. Ownership of beneficial interests in the Public Warrants shall
be shown on, and the transfer of such ownership shall be effected through, records maintained by institutions that have accounts
with the Depositary (such institution, with respect to a Warrant in its account, a “Participant”). If the Depositary
subsequently ceases to make its book-entry settlement system available for the Public Warrants, the Company may instruct the Warrant
Agent regarding making other arrangements for book-entry settlement. In the event that the Public Warrants are not eligible for,
or it is no longer necessary to have the Public Warrants available in, book-entry form, the Warrant Agent shall provide written
instructions to the Depositary to deliver to the Warrant Agent for cancellation each book- entry Public Warrant, and the Company
shall instruct the Warrant Agent to deliver to the Depositary definitive certificates in physical form evidencing such Warrants,
which shall be in the form annexed hereto as Exhibit A.

 

2.4.2. Registered
Holder. Prior to due presentment for registration of transfer of any Warrant, the Company and the Warrant Agent may deem and
treat the person in whose name such Warrant is then registered in the Warrant Register (“registered holder”)
as the absolute owner of such Warrant (notwithstanding any notation of ownership or other writing on the Warrant certificate made
by anyone other than the Company or the Warrant Agent), for the purpose of any exercise thereof, and for all other purposes, and
neither the Company nor the Warrant Agent shall be affected by any notice to the contrary.

 

2.4.3. Detachability
of Warrants. The securities comprising the Public Units will not be separately transferable until the 52nd day
following the date of the prospectus or, if such 52nd day is not on a day, other than Saturday, Sunday or federal
holiday, on which banks in New York City are generally open for normal business (a “Business Day”), then
on the immediately succeeding Business Day following such date, or earlier with the consent of  J.P. Morgan Securities
LLC, Barclays Capital Inc. and CIBC World Markets Corp. (together, the “Representatives”), but in no event
will the securities comprising the Public Units be separately traded until (i) the Company has filed a Current Report on Form
8-K which includes an audited balance sheet reflecting the receipt by the Company of the gross proceeds of the Public
Offering including the proceeds received by the Company from the exercise of the underwriters’ over-allotment option in
the Public Offering, if the over-allotment option is exercised prior to the filing of the Form 8-K, and (ii) the Company has
issued a press release announcing when such separate trading shall begin (the
“Detachment Date”).

 

2.4.4. No
Fractional Warrants Other Than as Part of Units. The Company shall not issue fractional Warrants other than as part of Units,
each of which is comprised of one or more full or partial shares of Common Stock and one or more full or partial Warrants. If,
upon the detachment of Warrants from Units or otherwise, a holder of Warrants would be entitled to receive, in respect of all such
Units of such Holder, a number of Warrants that includes a fractional Warrant, the Company shall round down, to the nearest whole
number, the aggregate number of Warrants to be issued to such holder in respect of all such Units.

 

2.5. Private
Placement Warrant and Working Capital Warrant Attributes. The Private Placement Warrants and Working Capital Warrants will
be issued in the same form as the Public Warrants but they (i) will not be redeemable by the Company and (ii) may be exercised
for cash or on a cashless basis at the holder’s option, in either case as long as they are held by the initial holders or
their permitted transferees (as prescribed in Section 5.6 hereof). Once a Private Placement Warrant or Working Capital Warrant
is transferred to a holder other than an affiliate or permitted transferee, it shall be treated as a Public Warrant hereunder for
all purposes.

 

2.6. Other
Post IPO Warrants. The Forward Purchase Warrants and other Post IPO Warrants, when and if issued, shall have the same terms
and be in the same form as the Public Warrants except as may be agreed upon by the Company.

 

    3

     

    

 

3. Terms
and Exercise of Warrants.

 

3.1. Warrant
Price. Each Warrant certificate shall, when countersigned by the Warrant Agent, and each Warrant represented by book entry shall,
entitle the registered holder thereof, subject to the provisions of such Warrant and of this Agreement, to purchase from the Company
the number of shares of Common Stock stated therein, at the price of $11.50 per share, subject to the adjustments provided in Section
4 hereof and in the last sentence of this Section 3.1. The term “Warrant Price” as used in this Agreement refers to
the price per share at which the shares of Common Stock may be purchased at the time a Warrant is exercised. The Company in its
sole discretion may lower the Warrant Price at any time prior to the Expiration Date (as defined below) for a period of not less
than twenty (20) Business Days; provided, that the Company shall provide at least twenty (20) days’ prior written notice
of such reduction to registered holders of the Warrants and, provided further that any such reduction shall be applied consistently
to all of the Warrants.

 

3.2. Duration
of Warrants. A Warrant may be exercised only during the period commencing on the later of 30 days after the consummation by
the Company of a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business
combination with one or more businesses or entities (“Business Combination”) (as described more fully in the
Registration Statement) or 12 months from the closing of the Public Offering, and terminating at 5:00 p.m., New York City time
on the earlier to occur of (i) five years from the consummation of a Business Combination, (ii) the Redemption Date as provided
in Section 6.2 of this Agreement and (iii) the liquidation of the Company (“Expiration Date”). The period of
time from the date the Warrants will first become exercisable until the expiration of the Warrants shall hereafter be referred
to as the “Exercise Period.” Except with respect to the right to receive the Redemption Price (as set forth
in Section 6 hereunder), as applicable, each Warrant not exercised on or before the Expiration Date shall become void, and all
rights thereunder and all rights in respect thereof under this Agreement shall cease at the close of business on the Expiration
Date. The Company in its sole discretion may extend the duration of the Warrants by delaying the Expiration Date; provided, however,
that the Company will provide at least twenty (20) days’ prior written notice of any such extension to registered holders
and, provided further that any such extension shall be applied consistently to all of the Warrants.

 

3.3. Exercise
of Warrants.

 

3.3.1. Payment.
Subject to the provisions of the Warrant and this Agreement, a Warrant may be exercised by the registered holder thereof by
(i) (A) when the certificate representing such Warrant has been countersigned by the Warrant Agent, surrendering such Warrant
certificate, at the office of the Warrant Agent, or at the office of its successor as Warrant Agent, in the Borough of
Manhattan, City and State of New York, with the subscription form, as set forth in the Warrant certificate, duly executed, or
(B) when the Warrant is represented by book entry, delivering the Warrant to an account of the Warrant Agent at the
Depositary designated for such purposes in writing by the Warrant Agent to the Depositary from time to time, with the
subscription form properly delivered by the Participant in accordance with the Depositary’s procedures, and (ii) paying
in full the Warrant Price for each share of Common Stock as to which such Warrants are exercised and any and all applicable
taxes due in connection with the exercise of the Warrants, as follows:

 

(a) by
good certified check or good bank draft payable to the order of the Warrant Agent or wire transfer; or

 

    4

     

    

 

(b) in
the event of redemption pursuant to Section 6 hereof in which the Company’s management has elected to force all holders of
Warrants to exercise such Warrants on a “cashless basis,” by surrendering the Warrants for that number of shares of
Common Stock equal to the quotient obtained by dividing (x) the product of the number of shares of Common Stock underlying the
Warrants, multiplied by the difference between the Warrant Price and the “Fair Market Value” (defined below) by (y)
the Fair Market Value. Solely for purposes of this Section 3.3.1(b), the “Fair Market Value” shall mean the average
last reported sale price of the Common Stock for the ten (10) trading days ending on the third trading day prior to the date on
which the notice of redemption is sent to holders of the Warrants pursuant to Section 6 hereof; or

 

(c) with
respect to any Private Placement Warrants or Working Capital Warrants, so long as such Private Placement Warrants or Working Capital
Warrants are held by the initial purchasers or their permitted transferees, by surrendering such Private Placement Warrants or
Working Capital Warrants for that number of shares of Common Stock equal to the quotient obtained by dividing (x) the product of
the number of shares of Common Stock underlying the Warrants, multiplied by the difference between the exercise price of the Warrants
and the “Fair Market Value” by (y) the Fair Market Value; provided, however, that no cashless exercise shall be permitted
unless the Fair Market Value is equal to or higher than the exercise price. Solely for purposes of this Section 3.3.1(c), the “Fair
Market Value” shall mean the average reported last sale price of the Common Stock for the ten (10) trading days ending on
the third trading day prior to the date of exercise; or

 

(d) in
the event the registration statement required by Section 7.4 hereof is not effective and current within ninety (90) days after
the closing of a Business Combination, by surrendering such Warrants for that number of shares of Common Stock equal to the quotient
obtained by dividing (x) the product of the number of shares of Common Stock underlying the Warrants, multiplied by the difference
between the exercise price of the Warrants and the “Fair Market Value” by (y) the Fair Market Value; provided, however,
that no cashless exercise shall be permitted unless the Fair Market Value is equal to or higher than the exercise price. Solely
for purposes of this Section 3.3.1(d), the “Fair Market Value” shall mean the average reported last sale price of the
Common Stock for the ten (10) trading days ending on the trading day prior to the date of exercise.

 

3.3.2. Issuance
of Shares of Common Stock. As soon as practicable after the exercise of any Warrant and the clearance of the funds in payment
of the Warrant Price (if any), the Company shall issue to the registered holder of such Warrant a certificate or certificates,
or book entry position, for the number of shares of Common Stock to which he, she or it is entitled, registered in such name or
names as may be directed by him, her or it, and if such Warrant shall not have been exercised in full, a new countersigned Warrant
certificate, or book entry position, for the number of shares as to which such Warrant shall not have been exercised. Notwithstanding
the foregoing, in no event will the Company be required to net cash settle the Warrant exercise. No Warrant shall be exercisable
for cash and the Company shall not be obligated to issue shares of Common Stock upon exercise of a Warrant unless the Common Stock
issuable upon such Warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state
of residence of the registered holder of the Warrants. In the event that the condition in the immediately preceding sentence is
not satisfied with respect to a Warrant, the holder of such Warrant shall not be entitled to exercise such Warrant for cash and
such Warrant may have no value and expire worthless, in which case the purchaser of a Unit containing such Warrants shall have
paid the full purchase price for the Unit solely for the shares of Common Stock underlying such Unit. Warrants may not be exercised
by, or securities issued to, any registered holder in any state in which such exercise would be unlawful. If, by reason of any exercise of Warrants on a “cashless
basis”, the holder of any Warrant would be entitled, upon the exercise of such Warrant, to receive a fractional interest
in a share of Common Stock, the Company shall round down to the nearest whole number, the number of shares of Common Stock to be
issued to such holder.

 

    5

     

    

 

3.3.3. Valid
Issuance. All shares of Common Stock issued upon the proper exercise of a Warrant in conformity with this Agreement shall be
validly issued, fully paid and nonassessable.

 

3.3.4. Date
of Issuance. Each person in whose name any book entry position or certificate for shares of Common Stock is issued shall for
all purposes be deemed to have become the holder of record of such shares on the date on which the Warrant certificate, or book
entry position representing such Warrant, was surrendered and payment of the Warrant Price was made, irrespective of the date of
delivery of such certificate, except that, if the date of such surrender and payment is a date when the share transfer books of
the Company or book entry system of the Warrant Agent are closed, such person shall be deemed to have become the holder of such
shares at the close of business on the next succeeding date on which the share transfer books or book entry system are open.

 

3.3.5. Maximum
Percentage. A holder of a Warrant may notify the Company in writing in the event it elects to be subject to the provisions
contained in this subsection 3.3.5; however, no holder of a Warrant shall be subject to this subsection 3.3.5 unless he, she or
it makes such election. If the election is made by a holder, the Warrant Agent shall not effect the exercise of the holder’s
Warrants, and such holder shall not have the right to exercise such Warrants, to the extent that after giving effect to such exercise,
such person (together with such person’s affiliates), to the Warrant Agent’s actual knowledge, would beneficially own
in excess of 9.8% (the “Maximum Percentage”) of the shares of Common Stock outstanding immediately after giving
effect to such exercise. For purposes of the foregoing sentence, the aggregate number of shares of Common Stock beneficially owned
by such person and its affiliates shall include the number of shares of Common Stock issuable upon exercise of the Warrants with
respect to which the determination of such sentence is being made, but shall exclude shares of Common Stock that would be issuable
upon (x) exercise of the remaining, unexercised portion of the Warrants beneficially owned by such person and its affiliates and
(y) exercise or conversion of the unexercised or unconverted portion of any other securities of the Company beneficially owned
by such person and its affiliates (including, without limitation, any convertible notes or convertible preferred stock or warrants)
subject to a limitation on conversion or exercise analogous to the limitation contained herein. Except as set forth in the preceding
sentence, for purposes of this paragraph, beneficial ownership shall be calculated in accordance with Section 13(d) of the Securities
Exchange Act of 1934, as amended (the “Exchange Act”). For purposes of the Warrants, in determining the number
of outstanding shares of Common Stock, the holder may rely on the number of outstanding shares of Common Stock as reflected in
(1) the Company’s most recent annual report on Form 10-K, quarterly report on Form 10-Q, current report on Form 8-K or other
public filing with the SEC as the case may be, (2) a more recent public announcement by the Company or (3) any other notice by
the Company or the Warrant Agent setting forth the number of shares of Common Stock outstanding. For any reason at any time, upon
the written request of the holder of the Warrant, the Company shall, within two (2) Business Days, confirm orally and in writing
to such holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock
shall be determined after giving effect to the conversion or exercise of equity securities of the Company by the holder and its
affiliates since the date as of which such number of outstanding shares of Common Stock was reported. By written notice to the
Company, the holder of Warrants may from time to time increase or decrease the Maximum Percentage applicable to such holder to
any other percentage specified in such notice; provided, however, that any such increase shall not be effective until the sixty-first
(61st) day after such notice is delivered to the Company.

 

    6

     

    

 

4. Adjustments.

 

4.1. Stock
Dividends; Split Ups. If after the date hereof, and subject to the provisions of Section 4.6 below, the number of outstanding
shares of Common Stock is increased by a stock dividend payable in shares of Common Stock, or by a split up of shares of Common
Stock, or other similar event, then, on the effective date of such stock dividend, split up or similar event, the number of shares
of Common Stock issuable on exercise of each Warrant shall be increased in proportion to such increase in outstanding shares of
Common Stock.

 

4.2. Aggregation
of Shares. If after the date hereof, the number of outstanding shares of Common Stock is decreased by a consolidation, combination,
reverse stock split or reclassification of shares of Common Stock or other similar event, then, on the effective date of such consolidation,
combination, reverse stock split, reclassification or similar event, the number of shares of Common Stock issuable on exercise
of each Warrant shall be decreased in proportion to such decrease in outstanding shares of Common Stock.

 

4.3. Extraordinary
Dividends. If the Company, at any time while the Warrants are outstanding and unexpired, shall pay a dividend or make a distribution
in cash, securities or other assets to the holders of the shares of Common Stock or other shares of the Company’s capital
stock into which the Warrants are convertible (an “Extraordinary Dividend”), then the Warrant Price shall be
decreased, effective immediately after the effective date of such Extraordinary Dividend, by the amount of cash and the fair market
value (as determined by the Company’s Board of Directors, in good faith) of any securities or other assets paid in respect
of such Extraordinary Dividend divided by all outstanding shares of the Company at such time (whether or not any shareholders waived
their right to receive such dividend); provided, however, that none of the following shall be deemed an Extraordinary Dividend
for purposes of this provision: (a) any adjustment described in subsection 4.1 above, (b) any cash dividends or cash distributions
which, when combined on a per share basis with all other cash dividends and cash distributions paid on the Common Stock during
the 365-day period ending on the date of declaration of such dividend or distribution does not exceed $0.50 per share (taking into
account all of the outstanding shares of the Company at such time (whether or not any shareholders waived their right to receive
such dividend) and as adjusted to appropriately reflect any of the events referred to in other subsections of this Section 4 and
excluding cash dividends or cash distributions that resulted in an adjustment to the Warrant Price or to the number of shares of
Common Stock issuable on exercise of each Warrant) but only with respect to the amount of the aggregate cash dividends or cash
distributions equal to or less than $0.50, (c) any payment to satisfy the conversion rights of the holders of the shares of Common
Stock in connection with a proposed initial Business Combination or certain amendments to the Company’s Amended and Restated
Certificate of Incorporation (as described in the Registration Statement) or (d) any payment in connection with the Company’s
liquidation and the distribution of its assets upon its failure to consummate a Business Combination. Solely for purposes of illustration,
if the Company, at a time while the Warrants are outstanding and unexpired, pays a cash dividend of $0.35 and previously paid an
aggregate of $0.40 of cash dividends and cash distributions on the Common Stock during the 365-day period ending on the date of
declaration of such $0.35 dividend, then the Warrant Price will be decreased, effectively immediately after the effective date
of such $0.35 dividend, by $0.25 (the absolute value of the difference between $0.75 (the aggregate amount of all cash dividends
and cash distributions paid or made in such 365-day period, including such $0.35 dividend) and $0.50 (the greater of (x) $0.50
and (y) the aggregate amount of all cash dividends and cash distributions paid or made in such 365-day period prior to such $0.35
dividend)). Furthermore, solely for the purposes of illustration, if following the closing of the Company’s initial Business
Combination, there were total shares outstanding of 100,000,000 and the Company paid a $1.00 dividend to 17,500,000 of such shares
(with the remaining 82,500,000 shares waiving their right to receive such dividend), then no adjustment to the Warrant Price would
occur as a $17.5 million dividend payment divided by 100,000,000 shares equals $0.175 per share which is less than $0.50 per share.

 

    7

     

    

 

4.4. Adjustments
in Exercise Price. Whenever the number of shares of Common Stock purchasable upon the exercise of the Warrants is adjusted,
as provided in Sections 4.1 and 4.2 above, the Warrant Price shall be adjusted (to the nearest cent) by multiplying such Warrant
Price immediately prior to such adjustment by a fraction (x) the numerator of which shall be the number of shares of Common Stock
purchasable upon the exercise of the Warrants immediately prior to such adjustment, and (y) the denominator of which shall be the
number of shares of Common Stock so purchasable immediately thereafter.

 

4.5. Replacement
of Securities upon Reorganization, etc. In case of any reclassification or reorganization of the outstanding shares of Common
Stock (other than a change under subsections 4.1 or 4.2 or Section 4.3 hereof or that solely affects the par value of such shares
of Common Stock), or in the case of any merger or consolidation of the Company with or into another entity or conversion of the
Company as another entity (other than a consolidation or merger in which the Company is the continuing corporation and that does
not result in any reclassification or reorganization of the outstanding shares of Common Stock), or in the case of any sale or
conveyance to another entity of the assets or other property of the Company as an entirety or substantially as an entirety in connection
with which the Company is dissolved, the holders of the Warrants shall thereafter have the right to purchase and receive, upon
the basis and upon the terms and conditions specified in the Warrants and in lieu of the shares of Common Stock of the Company
immediately theretofore purchasable and receivable upon the exercise of the rights represented thereby, the kind and amount of
shares of stock or other securities or property (including cash) receivable upon such reclassification, reorganization, merger
or consolidation, or upon a dissolution following any such sale or transfer, that the holder of the Warrants would have received
if such holder had exercised his, her or its Warrant(s) immediately prior to such event (the “Alternative Issuance”
); provided, however, that in connection with the closing of any such consolidation, merger, sale or conveyance, the successor
or purchasing entity shall execute an amendment hereto with the Warrant Agent providing for delivery of such Alternative Issuance;
provided, further, that (i) if the holders of the Common Stock were entitled to exercise a right of election as to the kind or
amount of securities, cash or other assets receivable upon such consolidation or merger, then the kind and amount of securities,
cash or other assets constituting the Alternative Issuance for which each Warrant shall become exercisable shall be deemed to be
the weighted average of the kind and amount received per share by the holders of the Common Stock in such consolidation or merger
that affirmatively make such election, and (ii) if a tender, exchange or redemption offer shall have been made to and accepted
by the holders of the Common Stock (other than a tender, exchange or redemption offer made by the Company in connection with redemption
rights held by stockholders of the Company as provided for in the Company’s amended and restated certificate of incorporation
or as a result of the repurchase of shares of Common Stock by the Company if a proposed initial Business Combination is presented
to the stockholders of the Company for approval) under circumstances in which, upon completion of such tender or exchange offer,
the maker thereof, together with members of any group (within the meaning of Rule 13d-5(b)(1) under the Exchange Act (or any successor
rule)) of which such maker is a part, and together with any affiliate or associate of such maker (within the meaning of Rule 12b-2
under the Exchange Act (or any successor rule)) and any members of any such group of which any such affiliate or associate is a
part, own beneficially (within the meaning of Rule 13d-3 under the Exchange Act (or any successor rule)) more than 50% of the outstanding
shares of Common Stock, the holder of a Warrant shall be entitled to receive as the Alternative Issuance, the highest amount of
cash, securities or other property to which such holder would actually have been entitled as a stockholder if such Warrant holder
had exercised the Warrant prior to the expiration of such tender or exchange offer, accepted such offer and all of the Common Stock
held by such holder had been purchased pursuant to such tender or exchange offer, subject to adjustments (from and after the consummation
of such tender or exchange offer) as nearly equivalent as possible to the adjustments provided for in this Section 4; provided,
further, that if less than 70% of the consideration receivable by the holders of the Common Stock in the applicable event is payable
in the form of common stock in the successor entity that is listed for trading on a national securities exchange or is quoted in
an established over-the-counter market, or is to be so listed for trading or quoted immediately following such event, and if the
Registered Holder properly exercises the Warrant within thirty (30) days following the public disclosure of the consummation of
such applicable event by the Company pursuant to a Current Report on Form 8-K filed with the Commission, the Warrant Price shall
be reduced by an amount (in dollars) (but in no event less than zero) equal to the difference of (i) the Warrant Price in effect
prior to such reduction minus (ii) (A) the Per Share Consideration (as defined below) minus (B) the Black-Scholes Warrant Value
(as defined below). The “Black-Scholes Warrant Value” means the value of a Warrant immediately prior to the
consummation of the applicable event based on the Black-Scholes Warrant Model for a Capped American Call on Bloomberg Financial
Markets (“Bloomberg”). For purposes of calculating such amount, (1) Section 6 of this Agreement shall be taken
into account, (2) the price of each share of Common Stock shall be the volume weighted average price of the Common Stock as reported
during the ten (10) trading day period ending on the trading day prior to the effective date of the applicable event, (3) the assumed
volatility shall be the 90 day volatility obtained from the HVT function on Bloomberg determined as of the trading day immediately
prior to the day of the announcement of the applicable event, and (4) the assumed risk-free interest rate shall correspond to the
U.S. Treasury rate for a period equal to the remaining term of the Warrant. “Per Share Consideration” means
(i) if the consideration paid to holders of the Common Stock consists exclusively of cash, the amount of such cash per share of
Common Stock, and (ii) in all other cases, the amount of cash per share of Common Stock, if any, plus the volume weighted average
price of the Common Stock as reported during the ten (10) trading day period ending on the trading day prior to the effective date
of the applicable event. If any reclassification or reorganization also results in a change in shares of Common Stock covered by
subsection 4.1, then such adjustment shall be made pursuant to subsection 4.1 or Sections 4.2, 4.3 and this Section 4.5. The provisions
of this Section 4.5 shall similarly apply to successive reclassifications, reorganizations, mergers or consolidations, sales or
other transfers. In no event will the Warrant Price be reduced to less than the par value per share issuable upon exercise of the
Warrant.

 

    8

     

    

 

4.6. Issuance
in connection with a Business Combination. If, in connection with a Business Combination, the Company (a) issues additional
shares of Common Stock or equity-linked securities at an issue price or effective issue price of less than $9.20 per share (with
such issue price or effective issue price as determined by the Company’s Board of Directors, in good faith, and in the case
of any such issuance to Northern Genesis Sponsor LLC, the initial stockholders, or their affiliates, without taking into account
any founders’ shares held by them prior to such issuance) (such price, the “Newly Issued Price”), (b)
the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available
for the funding of the Business Combination on the date of the consummation of such Business Combination (net of redemptions),
and (c) the Fair Market Value (as defined below) is below $9.20 per share, the exercise price of the warrants will be adjusted
(to the nearest cent) to be equal to 115% of the greater of (i) the Fair Market Value or (ii) the price at which the Company issues
the Common Stock or equity-linked securities and the Redemption Trigger Price (as defined below) shall be adjusted to equal to
180% of the greater of the Fair Market Value and the Newly Issued Price. Solely for purposes of this Section 4.6, the “Fair
Market Value” shall mean the volume weighted average reported trading price of the Common Stock for the twenty (20) trading
days starting on the trading day prior to the date of the consummation of the Business Combination.

 

4.7. Notices
of Changes in Warrant. Upon every adjustment of the Warrant Price or the number of shares issuable upon exercise of a Warrant,
the Company shall give written notice thereof to the Warrant Agent, which notice shall state the Warrant Price resulting from such
adjustment and the increase or decrease, if any, in the number of shares purchasable at such price upon the exercise of a Warrant,
setting forth in reasonable detail the method of calculation and the facts upon which such calculation is based. Upon the occurrence
of any event specified in Sections 4.1, 4.2, 4.3, 4.4, 4.5, or 4.6, then, in any such event, the Company shall give written notice
to each Warrant holder, at the last address set forth for such holder in the Warrant Register, of the record date or the effective
date of the event. Failure to give such notice, or any defect therein, shall not affect the legality or validity of such event.

 

4.8. No
Fractional Warrants or Shares. Notwithstanding any provision contained in this Agreement to the contrary, the Company shall
not issue fractional shares of Common Stock upon exercise of Warrants. If, by reason of any adjustment made pursuant to this Section
4, the holder of any Warrants would be entitled, upon the exercise of such Warrants, to receive in respect of all such Warrants
so exercised a number of shares of Common Stock that includes a fractional interest in a share, the Company shall, upon such exercise,
round down, to the nearest whole number of shares, the number of shares of Common Stock to be issued to the Warrant holder.

 

    9

     

    

 

4.9. Form
of Warrant Certificate. The form of Warrant certificate need not be changed because of any adjustment pursuant to this Section
4, and Warrant certificates issued after such adjustment may state the same Warrant Price and the same number of shares as is stated
in the Warrant certificates initially issued pursuant to this Agreement. However, the Company may at any time in its sole discretion
make any change in the form of Warrant certificate that the Company may deem appropriate and that does not affect the substance
thereof, and any Warrant certificate thereafter issued or countersigned, whether in exchange or substitution for an outstanding
Warrant or otherwise, may be in the form as so changed.

 

4.10. Other
Events. In case any event shall occur affecting the Company as to which none of the provisions of preceding subsections of
this Section 4 are strictly applicable, but which would require an adjustment to the terms of the Warrants in order to (i) avoid
an adverse impact on the Warrants and (ii) effectuate the intent and purpose of this Section 4, then, in each such case, the Company
shall appoint a firm of independent public accountants, investment banking or other appraisal firm of recognized national standing,
which shall give its opinion as to whether or not any adjustment to the rights represented by the Warrants is necessary to effectuate
the intent and purpose of this Section 4 and, if they determine that an adjustment is necessary, the terms of such adjustment.
The Company shall adjust the terms of the Warrants in a manner that is consistent with any adjustment recommended in such opinion.

 

5. Transfer
and Exchange of Warrants.

 

5.1. Registration
of Transfer. The Warrant Agent shall register the transfer, from time to time, of any outstanding Warrants upon the Warrant
Register, upon surrender of such Warrants for transfer (including, in the case of certificated Warrants, the Warrant certificate,
properly endorsed with signatures properly guaranteed) and accompanied by appropriate instructions for transfer. Upon any such
transfer, a new Warrant certificate representing an equal aggregate number of Warrants shall be issued and the old Warrant certificate
shall be cancelled by the Warrant Agent. In the case of certificated Warrants, the Warrants so cancelled shall be delivered by
the Warrant Agent to the Company from time to time upon request.

 

5.2. Procedure
for Surrender of Warrants. Warrants may be surrendered to the Warrant Agent, either in certificated form or in book entry position,
together with a written request for exchange or transfer, and thereupon the Warrant Agent shall issue in exchange therefor one
or more new Warrant certificates, or book entry positions, as requested by the registered holder of the Warrants so surrendered,
representing an equal aggregate number of Warrants; provided, however, that in the event that a Warrant certificate or book entry
position surrendered for transfer bears a restrictive legend, the Warrant Agent shall not cancel such Warrant certificate or book
entry position and issue a new Warrant certificate or book entry position in exchange therefor until the Warrant Agent has received
an opinion of counsel for the Company stating that such transfer may be made and indicating whether the new Warrant certificates
or book entry positions must also bear a restrictive legend.

 

5.3. Fractional
Warrants. The Warrant Agent shall not be required to effect any registration of transfer or exchange which will result in the
issuance of a Warrant certificate or book-entry position for only a fraction of a Warrant.

 

5.4. Service
Charges. No service charge shall be made for any exchange or registration of transfer of Warrants.

 

    10

     

    

 

5.5. Warrant
Execution and Countersignature. The Warrant Agent is hereby authorized to countersign and to deliver, in accordance with the
terms of this Agreement, the Warrant certificates required to be issued pursuant to the provisions of this Section 5, and the Company,
whenever required by the Warrant Agent, will supply the Warrant Agent with Warrant certificates duly executed on behalf of the
Company for such purpose.

 

5.6. Private
Placement Warrants and Working Capital Warrants. The Warrant Agent shall not register any transfer of Private Placement Warrants
or Working Capital Warrants until thirty (30) days after the consummation by the Company of an initial Business Combination, except
for the following transfers (the transferee of any of the following constituting a “permitted transferee”):

 

5.6.1.
A transfer by any registered holder to (a) any Related Person of such registered holder, (b) Northern Genesis Sponsor II LLC
or any person or entity that at the time of the applicable transfer is, or immediately prior to the closing of a Business
Combination was, an officer, manager, or member of Northern Genesis Sponsor II LLC, (c) any person that at the time of the
applicable transfer is, or immediately prior to the closing of a Business Combination was, an officer or director of the
Company, (d) any Related Person of any of the foregoing, or (e) any entity that is controlled by any combination of any of
the foregoing; in each case on the condition that prior to such registration for transfer, the Warrant Agent shall be
presented with written documentation confirming the transferee’s status as a permitted transferee and pursuant to which
such transferee (or the trustee or legal guardian for such transferee) agrees to be bound, solely with respect to the
Warrants so transferred, by the transfer restrictions contained in this section and any other applicable agreement by which
the transferor is bound with respect to such Warrants;

 

5.6.2. In
the case of a registered holder that is a natural person, a transfer by virtue of laws of descent and distribution upon death of
such registered holder, and a transfer pursuant to a qualified domestic relations order; in each case on the condition that prior
to such registration for transfer, the Warrant Agent shall be presented with written documentation confirming the transferee’s
status as a permitted transferee and pursuant to which such transferee (or the trustee or legal guardian for such transferee) agrees
to be bound, solely with respect to the Warrants so transferred, by the transfer restrictions contained in this section and any
other applicable agreement by which the transferor is bound with respect to such Warrants;

 

5.6.3. In
the case of a registered holder that is an entity, a transfers by virtue of the laws of the jurisdiction of an entity’s organization
and the entity’s organizational documents upon dissolution of the entity; in each case on the condition that prior to such
registration for transfer, the Warrant Agent shall be presented with written documentation confirming the transferee’s status
as a permitted transferee and pursuant to which such transferee (or the trustee or legal guardian for such transferee) agrees to
be bound, solely with respect to the Warrants so transferred, by the transfer restrictions contained in this section and any other
applicable agreement by which the transferor is bound with respect to such Warrants;

 

5.6.4. Following
the closing of a Business Combination, any transfer as a result of enforcement of rights and remedies under any bona fide hypothecation
or pledge of or other grant of a security interest in any such Warrant as security for indebtedness; in each case on the condition
that prior to such registration for transfer, the Warrant Agent shall be presented with written documentation either (a) confirming
that the transferee is not a person or entity to which such Warrants may be transferred pursuant to Section 5.6.1, or (b) pursuant
to which such transferee (or the trustee or legal guardian for such transferee) agrees to be bound, solely with respect to the
Warrants so transferred, by the transfer restrictions contained in this section and any other applicable agreement by which the
transferor is bound with respect to such Warrants;

 

    11

     

    

 

5.6.5. Any
transfer to or exchange with the Company (or successor issuer of such Warrants) to effectuate any stock split, reverse stock split,
reorganization, recapitalization, reclassification, combination, exchange of shares or other like change; provided, however,
that any such Warrants shall be subject to the restrictions of this Section 5.6 to the same extent as the Warrants so transferred
or exchanged.

 

As used in this
Section 5.6, “Related Person” means (a) in the case of a registered holder that is an entity, any securityholder,
partner, member or affiliate (as defined below) of such registered holder; and (b) in the case of a registered holder that is a
natural person, (i) any member of such registered holder’s immediate family (as defined below), (ii) any trust, the beneficiaries
of which are such registered holder, any Related Person of such registered holder, and/or any charitable organization, or the assets
of which are deemed for federal income tax purposes to be owned by such registered holder and/or one or more Related Persons of
such registered holder, or (iii) any entity that is directly or indirectly controlled by such registered holder and/or any combination
of any of the foregoing. For purposes of the foregoing, (A) “immediate family” of a specified person
means his or her spouse or domestic partner, any parent of such specified person or of his or her spouse or domestic partner, or
any lineal descendant of any of the foregoing (including by adoption), (B) “affiliate” of a specified
person or entity means any other person or entity that directly, or indirectly through one or more other affiliates, controls or
is controlled by, or is under common control with, the specified person or entity, and (C) “control”
means the possession, directly or indirectly, or as trustee or executor, of the power to direct or cause the direction of the management
and policies of a person, whether through the ownership of voting securities, as trustee or executor, by contract or otherwise,
and, in the case of a fund, includes the power to direct or cause the direction of the investment decisions of such fund, whether
through authority as the manager, investment manager, general partner, or otherwise.

 

5.6.6. Transfers
of Units; Transfers prior to Detachment. Each transfer of a Unit on the register relating to such Units shall operate also
to transfer the Warrants included in such Unit. Prior to the Detachment Date, the Public Warrants may be transferred or exchanged
only together with the Public Unit in which such Public Warrant is included, and only for the purpose of effecting, or in conjunction
with, a transfer or exchange of such Public Unit.

 

    12

     

    

 

6. Redemption.

 

6.1. Redemption.
Subject to Section 6.4 hereof, all, and not less than all, of the outstanding Warrants may be redeemed, at the option of the Company,
at any time during the Exercise Period, at the office of the Warrant Agent, upon the notice referred to in Section 6.2, at the
price of $0.01 per Warrant (“Redemption Price”), provided that the last sales price of the Common Stock equals
or exceeds $18.00 per share (subject to adjustment in accordance with Section 4 hereof) (the “Redemption Trigger Price”),
on each of twenty (20) trading days within any thirty (30) trading day period commencing after the Warrants become exercisable
and ending on the third trading day prior to the date on which notice of redemption is given and provided that there is an effective
registration statement covering the shares of Common Stock issuable upon exercise of the Warrants, and a current prospectus relating
thereto, available throughout the 30-day redemption or the Company has elected to require the exercise of the Warrants on a “cashless
basis” pursuant to subsection 3.3.1(b); provided, however, that if and when the Public Warrants become redeemable by the
Company, the Company may not exercise such redemption right if the issuance of shares of Common Stock upon exercise of the Public
Warrants is not exempt from registration or qualification under applicable state blue sky laws or the Company is unable to effect
such registration or qualification.

 

6.2. Date
Fixed for, and Notice of, Redemption. In the event the Company shall elect to redeem all of the Warrants that are subject to
redemption, the Company shall fix a date for the redemption (the “Redemption Date”). Notice of redemption shall
be mailed by first class mail, postage prepaid, by the Company not less than thirty (30) days prior to the Redemption Date to the
registered holders of the Warrants to be redeemed at their last addresses as they shall appear on the registration books. Any notice
mailed in the manner herein provided shall be conclusively presumed to have been duly given whether or not the registered holder
received such notice.

 

6.3. Exercise
After Notice of Redemption. The Public Warrants may be exercised, for cash (or on a “cashless basis” in accordance
with Section 3 of this Agreement) at any time after notice of redemption shall have been given by the Company pursuant to Section
6.2 hereof and prior to the Redemption Date. In the event the Company determines to require all holders of Public Warrants to exercise
their Warrants on a “cashless basis” pursuant to Section 3.3.1(b), the notice of redemption will contain the information
necessary to calculate the number of shares of Common Stock to be received upon exercise of the Warrants, including the “Fair
Market Value” in such case. On and after the Redemption Date, the record holder of the Warrants shall have no further rights
except to receive, upon surrender of the Warrants, the Redemption Price.

 

6.4. Exclusion
of Certain Warrants. The Company agrees that the redemption rights provided in this Section 6 shall not apply to (i) the Private
Placement Warrants and Working Capital Warrants if at the time of the redemption such Private Placement Warrants or Working Capital
Warrants continue to be held by the initial purchasers or their permitted transferees or (ii) Post IPO Warrants if such warrants
provide that they are non-redeemable by the Company. However, with respect to the Private Placement Warrants or Working Capital
Warrants, once such Private Placement Warrants or Working Capital Warrants are transferred (other than to permitted transferees
under Section 5.6), the Company may redeem the Private Placement Warrants and Working Capital Warrants in the same manner as the
Public Warrants.

 

    13

     

    

 

7. Other
Provisions Relating to Rights of Holders of Warrants.

 

7.1. No
Rights as Stockholder. A Warrant does not entitle the registered holder thereof to any of the rights of a stockholder of the
Company, including, without limitation, the right to receive dividends, or other distributions, exercise any preemptive rights
to vote or to consent or to receive notice as stockholders in respect of the meetings of stockholders or the election of directors
of the Company or any other matter.

 

7.2. Lost,
Stolen, Mutilated, or Destroyed Warrants. If any Warrant certificate is lost, stolen, mutilated, or destroyed, the Company
and the Warrant Agent may on such terms as to indemnity or otherwise as they may in their discretion impose (which shall, in the
case of a mutilated Warrant certificate, include the surrender thereof), issue a new Warrant certificate of like denomination,
tenor, and date as the Warrant certificate so lost, stolen, mutilated, or destroyed. Any such new Warrant certificate shall constitute
a substitute contractual obligation of the Company, whether or not the allegedly lost, stolen, mutilated, or destroyed Warrant
certificate shall be at any time enforceable by anyone.

 

7.3. Reservation
of Shares of Common Stock. The Company shall at all times reserve and keep available a number of its authorized but unissued
shares of Common Stock that will be sufficient to permit the exercise in full of all outstanding Warrants issued pursuant to this
Agreement.

 

7.4. Registration
of Common Stock; Cashless Exercise at Company’s Option.

 

7.4.1. Registration
of Common Stock. The Company agrees that as soon as practicable after the closing of its initial Business Combination,
but in no event later than fifteen (15) Business Days after the closing of its initial Business Combination, it shall use its
best efforts to file with the Securities and Exchange Commission a registration statement for the registration, under the
Act, of the shares of Common Stock issuable upon exercise of the Warrants, and it shall use its best efforts to take such
action as is necessary to register or qualify for sale, in those states in which the Warrants were initially offered by the
Company and in those states where holders of Warrants then reside, the shares of Common Stock issuable upon exercise of the
Warrants, to the extent an exemption is not available. The Company will use its best efforts to cause the same to become
effective and to maintain the effectiveness of such registration statement until the expiration of the Warrants in accordance
with the provisions of this Agreement. If any such registration statement has not been declared effective by the 60th day
following the closing of the Business Combination, holders of the Warrants shall have the right, during the period beginning
on the 61st day after the closing of the Business Combination and ending upon such registration statement being declared
effective by the Securities and Exchange Commission, and during any other period when the Company shall fail to have
maintained an effective registration statement covering the shares of Common Stock issuable upon exercise of the Warrants, to
exercise such Warrants on a “cashless basis” as determined in accordance with Section 3.3.1(d). The Company shall
provide the Warrant Agent with an opinion of counsel for the Company (which shall be an outside law firm with securities law
experience) stating that (i) the exercise of the Warrants on a cashless basis in accordance with this Section 7.4 is not
required to be registered under the Act and (ii) the shares of Common Stock issued upon such exercise will be freely tradable
under U.S. federal securities laws by anyone who is not an affiliate (as such term is defined in Rule 144 under the Act) of
the Company and, accordingly, will not be required to bear a restrictive legend. For the avoidance of any doubt, unless and
until all of the Warrants have been exercised on a cashless basis or have expired, the Company shall continue to be obligated to
comply with its registration obligations under the first three sentences of this Section 7.4.

 

    14

     

    

 

7.4.2. Cashless
Exercise at Company’s Option. If the Common Stock is at the time of any exercise of a Warrant not listed on a national
securities exchange such that it satisfies the definition of a “covered security” under Section 18(b)(1) of the Securities
Act (or any successor statute), the Company may, at its option, (i) require holders of Public Warrants who exercise Public Warrants
to exercise such Public Warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act (or
any successor statute) as described in subsection 7.4.1 and (ii) in the event the Company so elects, the Company shall not be required
to file or maintain in effect a registration statement for the registration, under the Securities Act, of the Common Stock issuable
upon exercise of the Warrants, notwithstanding anything in this Agreement to the contrary. If the Company does not elect at the
time of exercise to require a holder of Public Warrants who exercises Public Warrants to exercise such Public Warrants on a “cashless
basis,” it agrees to use its best efforts to register or qualify for sale the Common Stock issuable upon exercise of the
Public Warrant under the blue sky laws of the state of residence of the exercising Public Warrant holder to the extent an exemption
is not available.

 

8. Concerning
the Warrant Agent and Other Matters.

 

8.1. Payment
of Taxes. The Company will from time to time promptly pay all taxes and charges that may be imposed upon the Company or the
Warrant Agent in respect of the issuance or delivery of shares of Common Stock upon the exercise of Warrants, but the Company shall
not be obligated to pay any transfer taxes in respect of the Warrants or such shares.

 

8.2. Resignation,
Consolidation, or Merger of Warrant Agent.

 

8.2.1. Appointment
of Successor Warrant Agent. The Warrant Agent, or any successor to it hereafter appointed, may resign its duties and be discharged
from all further duties and liabilities hereunder after giving sixty (60) days’ notice in writing to the Company. If the
office of the Warrant Agent becomes vacant by resignation or incapacity to act or otherwise, the Company shall appoint in writing
a successor Warrant Agent in place of the Warrant Agent. If the Company shall fail to make such appointment within a period of
thirty (30) days after it has been notified in writing of such resignation or incapacity by the Warrant Agent or by the holder
of the Warrant (who shall, with such notice, submit his Warrant for inspection by the Company), then the holder of any Warrant
may apply to the Supreme Court of the State of New York for the County of New York for the appointment of a successor Warrant Agent
at the Company’s cost. Any successor Warrant Agent, whether appointed by the Company or by such court, shall be a corporation
organized and existing under the laws of the State of New York, in good standing and having its principal office in the Borough
of Manhattan, City and State of New York, and authorized under such laws to exercise corporate trust powers and subject to supervision
or examination by federal or state authority. After appointment, any successor Warrant Agent shall be vested with all the authority,
powers, rights, immunities, duties, and obligations of its predecessor Warrant Agent with like effect as if originally named as
Warrant Agent hereunder, without any further act or deed; but if for any reason it becomes necessary or appropriate, the predecessor
Warrant Agent shall execute and deliver, at the expense of the Company, an instrument transferring to such successor Warrant Agent
all the authority, powers, and rights of such predecessor Warrant Agent hereunder; and upon request of any successor Warrant Agent
the Company shall make, execute, acknowledge, and deliver any and all instruments in writing for more fully and effectually vesting
in and confirming to such successor Warrant Agent all such authority, powers, rights, immunities, duties, and obligations.

 

    15

     

    

 

8.2.2. Notice
of Successor Warrant Agent. In the event a successor Warrant Agent shall be appointed, the Company shall give notice thereof
to the predecessor Warrant Agent and the transfer agent for the shares of Common Stock not later than the effective date of any
such appointment.

 

8.2.3. Merger
or Consolidation of Warrant Agent. Any corporation into which the Warrant Agent may be merged or with which it may be consolidated
or any corporation resulting from any merger or consolidation to which the Warrant Agent shall be a party shall be the successor
Warrant Agent under this Agreement without any further act.

 

8.3. Fees
and Expenses of Warrant Agent.

 

8.3.1. Remuneration.
The Company agrees to pay the Warrant Agent reasonable remuneration for its services as such Warrant Agent hereunder and will reimburse
the Warrant Agent upon demand for all expenditures that the Warrant Agent may reasonably incur in the execution of its duties hereunder.

 

8.3.2. Further
Assurances. The Company agrees to perform, execute, acknowledge, and deliver or cause to be performed, executed, acknowledged,
and delivered all such further and other acts, instruments, and assurances as may reasonably be required by the Warrant Agent for
the carrying out or performing of the provisions of this Agreement.

 

8.4. Liability
of Warrant Agent.

 

8.4.1. Reliance
on Company Statement. Whenever in the performance of its duties under this Agreement, the Warrant Agent shall deem it necessary
or desirable that any fact or matter be proved or established by the Company prior to taking or suffering any action hereunder,
such fact or matter (unless other evidence in respect thereof be herein specifically prescribed) may be deemed to be conclusively
proved and established by a statement signed by the Chief Executive Officer or Board Chair of the Company and delivered to the
Warrant Agent. The Warrant Agent may rely upon such statement for any action taken or suffered in good faith by it pursuant to
the provisions of this Agreement.

 

8.4.2. Indemnity.
The Warrant Agent shall be liable hereunder only for its own fraud, gross negligence, willful misconduct or bad faith. The Company
agrees to indemnify the Warrant Agent and save it harmless against any and all liabilities, including judgments, costs and reasonable
counsel fees, for anything done or omitted by the Warrant Agent in the execution of this Agreement except as a result of the Warrant
Agent’s fraud, gross negligence, willful misconduct, or bad faith.

 

8.4.3. Exclusions.
The Warrant Agent shall have no responsibility with respect to the validity of this Agreement or with respect to the validity or
execution of any Warrant (except its countersignature thereof); nor shall it be responsible for any breach by the Company of any
covenant or condition contained in this Agreement or in any Warrant; nor shall it be responsible to make any adjustments required
under the provisions of Section 4 hereof or responsible for the manner, method, or amount of any such adjustment or the ascertaining
of the existence of facts that would require any such adjustment; nor shall it by any act hereunder be deemed to make any representation
or warranty as to the authorization or reservation of any shares of Common Stock to be issued pursuant to this Agreement or any
Warrant or as to whether any shares of Common Stock will, when issued, be valid and fully paid and nonassessable.

 

    16

     

    

 

8.4.4. Acceptance
of Agency. The Warrant Agent hereby accepts the agency established by this Agreement and agrees to perform the same upon the
terms and conditions herein set forth and among other things, shall account promptly to the Company with respect to Warrants exercised
and concurrently account for, and pay to the Company, all monies received by the Warrant Agent for the purchase of shares of Common
Stock through the exercise of Warrants.

 

9. Miscellaneous
Provisions.

 

9.1. Successors.
All the covenants and provisions of this Agreement by or for the benefit of the Company or the Warrant Agent shall bind and inure
to the benefit of their respective successors and assigns.

 

9.2. Notices.
Any notice, statement or demand authorized by this Agreement to be given or made by the Warrant Agent or by the holder of any Warrant
to or on the Company shall be sufficiently given when so delivered if by hand or overnight delivery or if sent by certified mail
or private courier service within five (5) days after deposit of such notice, postage prepaid, addressed (until another address
is filed in writing by the Company with the Warrant Agent), as follows:

 

Northern
Genesis Acquisition Corp. II

4801
Main Street, Suite 1000

Kansas
City, MO 64112

Attn:
Chief Financial Officer

 

Any notice, statement
or demand authorized by this Agreement to be given or made by the holder of any Warrant or by the Company to or on the Warrant
Agent shall be sufficiently given when so delivered if by hand or overnight delivery or if sent by certified mail or private courier
service within five days after deposit of such notice, postage prepaid, addressed (until another address is filed in writing by
the Warrant Agent with the Company), as follows:

 

Continental
Stock Transfer & Trust Company

1 State
Street

New York,
New York 10004

Attn:
Compliance Department

 

with a copy in
each case to:

 

Husch Blackwell LLP

4801 Main Street, Suite 100

Kansas City, Missori 64112

Attn: James Goettsch, Esq.

E-mail: jim.goettsch@huschblackwell.com

 

    17

     

    

 

and

 

Davis Polk & Wardwell LLP

450 Lexington Avenue

New York, New York 10017

(fax: (212) 701-5322)

Attn: Derek Dostal, Esq. and Roshni Banker Cariello,
Esq.

Email: roshni.cariello@davispolk.com

 

and

 

J.P. Morgan Securities LLC

383 Madison Avenue

New York, New York 10179

Attn: Equity Syndicate Desk

 

and

 

Barclays Capital Inc.

745 Seventh Avenue

New York, New York 10019

Attn: Syndicate Registration

 

and

 

CIBC World Markets Corp.

425 Lexington Avenue, 3rd Floor

New York, New York 10017

Attn: General Counsel

 

9.3. Applicable
Law. The validity, interpretation, and performance of this Agreement and of the Warrants shall be governed in all respects
by the laws of the State of New York, without giving effect to conflicts of law principles that would result in the application
of the substantive laws of another jurisdiction. The Company hereby agrees that any action, proceeding or claim against it arising
out of or relating in any way to this Agreement shall be brought and enforced in the courts of the State of New York or the United
States District Court for the Southern District of New York, and irrevocably submits to such jurisdiction. The Company hereby waives
any objection that such courts represent an inconvenient forum. Any such process or summons to be served upon the Company may be
served by transmitting a copy thereof by registered or certified mail, return receipt requested, postage prepaid, addressed to
it at the address set forth in Section 9.2 hereof. Such mailing shall be deemed personal service and shall be legal and binding
upon the Company in any action, proceeding or claim. The foregoing shall not relate to any claims brought under the Securities
Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.

 

    18

     

    

 

9.4. Persons
Having Rights under this Agreement. Nothing in this Agreement expressed and nothing that may be implied from any of the provisions
hereof is intended, or shall be construed, to confer upon, or give to, any person or corporation other than the parties hereto
and the registered holders of the Warrants and, for the purposes of Sections 7.4, 9.4 and 9.8 hereof, the Representatives, any
right, remedy, or claim under or by reason of this Warrant Agreement or of any covenant, condition, stipulation, promise, or agreement
hereof. The Representatives shall be deemed to be third party beneficiaries of this Agreement with respect to Sections 7.4, 9.4
and 9.8. All covenants, conditions, stipulations, promises, and agreements contained in this Warrant Agreement shall be for the
sole and exclusive benefit of the parties hereto (and the Representatives with respect to the Sections 7.4, 9.4 and 9.8 hereof)
and their successors and assigns and of the registered holders of the Warrants.

 

9.5. Examination
of the Warrant Agreement. A copy of this Agreement shall be available at all reasonable times at the office of the Warrant
Agent in the Borough of Manhattan, City and State of New York, for inspection by the registered holder of any Warrant. The Warrant
Agent may require any such holder to submit his Warrant for inspection by it.

 

9.6. Counterparts.
This Agreement may be executed in any number of original or facsimile counterparts and each of such counterparts shall for all
purposes be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument.

 

9.7. Effect
of Headings. The section headings herein are for convenience only and are not part of this Agreement and shall not affect the
interpretation thereof.

 

9.8. Amendments.
This Agreement may be amended by the parties hereto without the consent of any registered holder for the purpose of curing any
ambiguity, or of curing, correcting or supplementing any defective provision contained herein, conforming the provisions hereof to the description of the
terms of the Warrants and this Agreement set forth in the Registration Statement or adding or changing any other provisions
with respect to matters or questions arising under this Agreement as the parties may deem necessary or desirable and that the parties
deem shall not adversely affect the interest of the registered holders. All other modifications or amendments, including any amendment
to increase the Warrant Price or shorten the Exercise Period, shall require the written consent or vote of the registered holders
of (i) a majority of the then outstanding Public Warrants if such modification or amendment is being undertaken prior to, or in
connection with, the consummation of a Business Combination or (ii) a majority of the then outstanding Warrants if such modification
or amendment is being undertaken after the consummation of a Business Combination. Notwithstanding the foregoing, the Company may
lower the Warrant Price or extend the duration of the Exercise Period pursuant to Sections 3.1 and 3.2, respectively, without the
consent of the registered holders. The provisions of this Section 9.8 may not be modified, amended or deleted without the prior
written consent of the Representatives.

 

9.9. Trust
Account Waiver. The Warrant Agent acknowledges and agrees that it shall not make any claims or proceed against the trust account
established by the Company in connection with the Public Offering (as more fully described in the Registration Statement) (“Trust
Account”), including by way of set-off, and shall not be entitled to any funds in the Trust Account under any circumstance.
In the event that the Warrant Agent has a claim against the Company under this Agreement, the Warrant Agent will pursue such claim
solely against the Company and not against the property held in the Trust Account.

 

9.10. Severability.
This Agreement shall be deemed severable, and the invalidity or unenforceability of any term or provision hereof shall not affect
the validity or enforceability of this Agreement or of any other term or provision hereof. Furthermore, in lieu of any such invalid
or unenforceable term or provision, the parties hereto intend that there shall be added as a part of this Agreement a provision
as similar in terms to such invalid or unenforceable provision as may be possible and be valid and enforceable.

 

[signature page
follows]

 

    19

     

    

 

IN
WITNESS WHEREOF, this Agreement has been duly executed by the parties hereto as of the day and year first above written.

 

	 	NORTHERN GENESIS ACQUISITION CORP. II
	 	 	 
	 	By:	       
	 	 	Name: 
	 	 	Title: 
	 	 
	 	CONTINENTAL STOCK TRANSFER & TRUST COMPANY
	 	 	 
	 	By:	 
	 	 	Name:
	 	 	Title:

 

[Signature Page to Warrant Agreement]

 

 

20Exhibit 10.1

 

[____________ __, 2021]

 

Northern
Genesis Acquisition Corp. II

4801 Main
Street, Suite 1000

Kanas City,
MO 64112

 

J.P. Morgan
Securities LLC

383 Madison
Avenue

New York,
New York 10179

 

Barclays
Capital Inc.

745 Seventh
Avenue

New York,
New York 10019

 

CIBC World
Markets Corp.

425 Lexington
Avenue, 3rd Floor

New York,
New York 10017

 

Re: Initial Public Offering

 

Gentlemen:

 

This letter is being
delivered to you in accordance with the Underwriting Agreement (the “Underwriting Agreement”) entered
into by and between Northern Genesis Acquisition Corp. II, a Delaware corporation (the “Company”), and
J.P. Morgan Securities LLC, Barclays Capital Inc. and CIBC World Markets Corp. as representatives (the “Representatives”)
of the several Underwriters named in Schedule I thereto (the “Underwriters”), relating to an underwritten
initial public offering (the “IPO”) of the Company’s units (the “Units”),
each comprised of one share of the Company’s common stock, par value $0.0001 per share (the “Common Stock”),
and one-third of one warrant, each whole warrant exercisable for one share of Common Stock (each, a “Warrant”).
Certain capitalized terms used herein are defined in paragraph 13 hereof.

 

In order to induce
the Company and the Underwriters to enter into the Underwriting Agreement and to proceed with the IPO, and in recognition of the
benefit that such IPO will confer upon the undersigned, and for other good and valuable consideration, the receipt and sufficiency
of which are hereby acknowledged, the undersigned hereby agrees with the Company as follows:

 

1. Vote in Respect
of a Business Combination. If the Company solicits approval of its stockholders of a merger, share exchange, asset acquisition,
stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities
(a “Business Combination”), the undersigned will vote all shares of Common Stock beneficially owned by
him, her, or it, whether acquired before, in, or after the IPO, in favor of such Business Combination.

 

     

     

    

 

2. Cash Conversion
(Redemption) Rights.

 

(a) The undersigned hereby
waives any right to exercise, and agrees not to exercise, cash conversion (redemption) rights as set forth in the Company’s
Amended and Restated Certificate of Incorporation, as the same may be amended from time to time (the “Certificate of
Incorporation”) with respect to any shares of the Company’s common stock owned or to be owned by the undersigned,
directly or indirectly, whether such shares be part of the shares of Common Stock issued prior to the IPO (the “Founder
Shares”) or shares of Common Stock issued in the IPO (the “Public Shares”) and purchased
by the undersigned in the IPO or in the aftermarket, in connection with any vote to approve a Business Combination or in connection
with any vote to amend Article Sixth of the Certificate of Incorporation. In addition, if the Company provides all holders of its
Common Stock with an opportunity to sell their shares to the Company, effective upon consummation of such Business Combination,
for cash through a tender offer, the undersigned agrees not to tender or sell any of such shares to the Company in such tender
offer.

 

(b) The undersigned hereby
agrees to not propose, or vote in favor of, an amendment to Article Sixth of the Certificate of Incorporation other than in connection
with the consummation of a Business Combination (and that does not adversely affect the cash conversion rights of any public stockholders
with respect to Public Shares in connection with such Business Combination) unless the Company provides public stockholders with
the opportunity to convert their shares of Common Stock upon such approval in accordance with such Article Sixth thereof.

 

3. Liquidating Distributions.

 

(a) In the event that
the Company fails to consummate a Business Combination within the time period set forth in the Certificate of Incorporation, the
undersigned will, as promptly as possible, cause the Company to pay in cash to the holders of Public Shares a per-share price equal
to the aggregate amount then on deposit in the Trust Account, including interest earned on the Trust Account net of interest released
to the Company as permitted pursuant to the Trust Agreement, divided by the number of then outstanding Public Shares. As used herein,
“Trust Account” means the trust account into which the net proceeds of the IPO and a portion of the net
proceeds of the concurrent private placement of Warrants will be deposited, and “Trust Agreement” means
the Investment Management Trust Agreement between the Company and Continental Stock Transfer & Trust Company being entered
into in connection with the IPO and governing the use of funds held in the Trust Account.

 

(b) The undersigned hereby
waives any and all right, title, interest or claim of any kind in or to any distribution of the Trust Account (“Claim”)
with respect to any Founder Shares owned by the undersigned and hereby waives any Claim the undersigned may have in the future
as a result of, or arising out of, any contracts or agreements with the Company and will not seek recourse against the Trust Account
for any reason whatsoever, except for any rights to liquidating distributions that the undersigned may have in respect of any Public
Shares held by the undersigned from time to time. The undersigned acknowledges and agrees that there will be no distribution from
the Trust Account with respect to any Warrants, all rights of which will terminate on any liquidation of the Company.

 

    2

     

    

 

(c) [In the event of
the liquidation of the Trust Account, the undersigned agrees to indemnify and hold harmless the Company for any debts and obligations
to target businesses or vendors or other entities that are owed money by the Company for services rendered or contracted for or
products sold to the Company, but the liability of the undersigned in respect of such indemnification and hold harmless obligation
shall be limited to the amount of the then-existing net assets of the undersigned and only to the extent necessary to ensure that
such debt or obligation does not reduce the amount of funds in the Trust Account below the lesser of (x) $10.00 per Public Share
or (y) such lesser amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due
to reductions in the value of the trust assets, in each case net of the interest which may be withdrawn to pay the Company’s
tax obligations and up to $100,000 for liquidation expenses; provided that such indemnity shall not apply (i) if such vendor or
prospective target business executed an agreement waiving any right, title, interest or claim of any kind they may have in or to
any monies held in the Trust Account, or (ii) as to any claims under the Company’s obligation to indemnify the Underwriters
against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”).
For the avoidance of doubt, all obligations and liabilities of the undersigned, including those under or in connection with this
agreement, are solely the liabilities and obligations of the undersigned and are without recourse to any member, managing member,
officer, employee, or other affiliate or representative of the undersigned.]1

 

4. Transfer Restrictions.

 

(a) The undersigned agrees
that until the Company consummates a Business Combination, all Founder Shares owned by the undersigned will be subject to the transfer
restrictions described in the subscription agreement relating to the Founder Shares between the Company and Northern Genesis Sponsor
LLC (“Sponsor”) or its permitted transferees.

 

(b) The undersigned agrees
that until the Company consummates a Business Combination, all Warrants that are being sold privately by the Company simultaneously
with the consummation of the IPO (“Private Placement Warrants”) and the shares of Common Stock underlying
such Private Placement Warrants, and all Warrants that may be issued in satisfaction of loans to the Company (“Working
Capital Warrants”) and the shares of Common Stock underlying such Working Capital Warrants, that in either case are
owned by the undersigned will be subject to the transfer restrictions described in the subscription agreement relating to the Private
Placement Warrants between the Company and Sponsor or its permitted transferees.

 

5. Related Party
Business Combination. The undersigned acknowledges and agrees that prior to entering into a Business Combination with a target
business that is affiliated with Sponsor, any officer or director of the Company, or any of their respective affiliates, such transaction
must be approved by a majority of the Company’s disinterested independent directors and the Company must obtain an opinion
from an independent investment banking firm, or another independent entity that commonly renders valuation opinions, that such
Business Combination is fair to the Company’s unaffiliated stockholders from a financial point of view.

 

 

		1	For Sponsor letter only

 

    3

     

    

 

6. Compensation.
Neither the undersigned nor any affiliate of the undersigned will be entitled to receive and will not accept any compensation,
finder fee or other cash payment prior to, or for services rendered in order to effectuate, the consummation of the Business Combination,
except as otherwise described in the Company’s registration statement on Form S-1 (SEC File No. 333-251639) filed with the
Securities and Exchange Commission in relation to the IPO.

 

7. Conflicts of
Interest. In order to minimize potential conflicts of interest that may arise from multiple corporate affiliations, the undersigned
hereby agrees that until the earliest of the Company’s initial Business Combination or liquidation, the undersigned shall
present to the Company for its consideration, prior to presentation to any other entity, any suitable target business, subject
to any fiduciary or contractual obligations the undersigned might have.

 

8. Directors and
Officers.2

 

(a) The undersigned agrees
to continue to serve as a director and/or officer of the Company until the earlier of the consummation by the Company of a Business
Combination or the liquidation of the Company.

 

(b) The undersigned’s
biographical information previously furnished to the Company and the Representatives is true and accurate in all respects, does
not omit any material information with respect to the undersigned’s background and contains all of the information required
to be disclosed pursuant to Item 401 of Regulation S-K, promulgated under the Securities Act.

 

(c) The undersigned has
full right and power, without violating any agreement by which he, she or it is bound, to enter into this letter agreement and
to serve as a director and/or officer of the Company.

 

(d) If and for so long
as the undersigned serves as an officer of the Company, the undersigned agrees not to become an officer or director of any other
special purpose acquisition company which has publicly filed a registration statement with the SEC, unless (i) the Company has
entered into a definitive agreement regarding an initial Business Combination and such agreement remains in effect, or (ii) the
Company has commenced liquidation as a result of a failure to complete an initial Business Combination within 24 months after the
closing of the IPO; provided, however, that the foregoing shall not prohibit continued service as an officer or director of any
other special purpose acquisition company that the undersigned accepted when not prohibited by this restriction.

 

9. Representations
and Warranties. The undersigned’s FINRA Questionnaire previously furnished to the Company and the Representatives is
true and accurate in all respects. The undersigned represents and warrants that the undersigned:

 

(a) has never had a petition
under the federal bankruptcy laws or any state insolvency law been filed by or against (i) the undersigned or any partnership in
which the undersigned was a general partner at or within two years before the time of filing; or (ii) any corporation or business
association of which the undersigned was an executive officer at or within two years before the time of such filing;

 

 

		2	For Director/Officer letter only.

 

    4

     

    

 

(b) has never had a receiver,
fiscal agent or similar officer been appointed by a court for his/her/its business or property, or any such partnership;

 

(c) has never been convicted
of fraud in a civil or criminal proceeding;

 

(d) has never been convicted
in a criminal proceeding or named the subject of a pending criminal proceeding (excluding traffic violations and minor offenses);

 

(e) has never been the
subject of any order, judgment or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction,
permanently or temporarily enjoining or otherwise limiting him/her/it from (i) acting as a futures commission merchant, introducing
broker, commodity trading advisor, commodity pool operator, floor broker, leverage transaction merchant, any other person regulated
by the Commodity Futures Trading Commission (“CFTC”) or an associated person of any of the foregoing,
or as an investment adviser, underwriter, broker or dealer in securities, or as an affiliated person, director or employee of any
investment company, bank, savings and loan association or insurance company, or from engaging in or continuing any conduct or practice
in connection with any such activity; or (ii) engaging in any type of business practice; or (iii) engaging in any activity in connection
with the purchase or sale of any security or commodity or in connection with any violation of federal or state securities or federal
commodities laws;

 

(f) has never been the
subject of any order, judgment or decree, not subsequently reversed, suspended or vacated, of any federal or state authority barring,
suspending or otherwise limiting for more than 60 days the undersigned’s right to engage in any activity described in 9(e)(i)
above, or to be associated with persons engaged in any such activity;

 

(g) has never been found
by a court of competent jurisdiction in a civil action or by the SEC to have violated any federal or state securities law, where
the judgment in such civil action or finding by the SEC has not been subsequently reversed, suspended or vacated;

 

(h) has never been found
by a court of competent jurisdiction in a civil action or by the CFTC to have violated any federal commodities law, where the judgment
in such civil action or finding by the CFTC has not been subsequently reversed, suspended or vacated;

 

(i) has never been the
subject of, or a party to, any Federal or State judicial or administrative order, judgment, decree or finding, not subsequently
reversed, suspended or vacated, relating to an alleged violation of (i) any Federal or State securities or commodities law or regulation,
(ii) any law or regulation respecting financial institutions or insurance companies including, but not limited to, a temporary
or permanent injunction, order of disgorgement or restitution, civil money penalty or temporary or permanent cease-and desist order,
or removal or prohibition order or (iii) any law or regulation prohibiting mail or wire fraud or fraud in connection with any business
entity;

 

(j) has never been the
subject of, or party to, any sanction or order, not subsequently reversed, suspended or vacated, or any self-regulatory organization,
any registered entity, or any equivalent exchange, association, entity or organization that has disciplinary authority over its
members or persons associated with a member;

 

    5

     

    

 

(k) has never been convicted
of any felony or misdemeanor: (i) in connection with the purchase or sale of any security; (ii) involving the making of any false
filing with the SEC; or (iii) arising out of the conduct of the business of an underwriter, broker, dealer, municipal securities
dealer, investment advisor or paid solicitor of purchasers of securities;

 

(l) has never been subject
to a final order of a state securities commission (or an agency of officer of a state performing like functions); a state authority
that supervises or examines banks, savings associations, or credit unions; a state insurance commission (or an agency or officer
of a state performing like functions); an appropriate federal banking agency; the Commodity Futures Trading Commission; or the
National Credit Union Administration that is based on a violation of any law or regulation that prohibits fraudulent, manipulative,
or deceptive conduct;

 

(m) has never been subject
to any order, judgment or decree of any court of competent jurisdiction, that, at the time of such sale, restrained or enjoined
him/her/it from engaging or continuing to engage in any conduct or practice: (i) in connection with the purchase or sale of any
security; (ii) involving the making of any false filing with the SEC; or (iii) arising out of the conduct of the business of an
underwriter, broker, dealer, municipal securities dealer, investment adviser or paid solicitor of purchasers of securities;

 

(n) has never been subject
to any order of the SEC that orders him/her/it to cease and desist from committing or causing a future violation of: (i) any scienter-based
anti-fraud provision of the federal securities laws, including, but not limited to, Section 17(a)(1) of the Securities Act, Section
10(b) of the Exchange Act and Rule 10b-5 thereunder, and Section 206(1) of the Advisers Act or any other rule or regulation thereunder;
or (ii) Section 5 of the Securities Act;

 

(o) has never been named
as an underwriter in any registration statement or Regulation A offering statement filed with the SEC that was the subject of a
refusal order, stop order, or order suspending the Regulation A exemption, or is, currently, the subject of an investigation or
proceeding to determine whether a stop order or suspension order should be issued;

 

(p) has never been subject
to a United States Postal Service false representation order, or is currently subject to a temporary restraining order or preliminary
injunction with respect to conduct alleged by the United States Postal Service to constitute a scheme or device for obtaining money
or property through the mail by means of false representations;

 

(q) is not subject to
a final order of a state securities commission (or an agency of officer of a state performing like functions); a state authority
that supervises or examines banks, savings associations, or credit unions; a state insurance commission (or an agency or officer
of a state performing like functions); an appropriate federal banking agency; the Commodity Futures Trading Commission; or the
National Credit Union Administration that bars the undersigned from: (i) association with an entity regulated by such commission,
authority, agency or officer; (ii) engaging in the business of securities, insurance or banking; or (iii) engaging in savings association
or credit union activities;

 

    6

     

    

 

(r) is not subject to
an order of the SEC entered pursuant to section 15(b) or 15B(c) of the Securities Exchange Act of 1934, as amended (the “Exchange
Act”), or section 203(e) or 203(f) of the Investment Advisers Act of 1940, as amended (the “Advisers
Act”), that: (i) suspends or revokes the undersigned’s registration as a broker, dealer, municipal securities
dealer or investment adviser; (ii) places limitations on the activities, functions or operations of, or imposes civil money penalties
on, such person; or (iii) bars the undersigned from being associated with any entity or from participating in the offering of any
penny stock; and

 

(s) has never been suspended
or expelled from membership in, or suspended or barred from association with a member of, a securities self-regulatory organization
(e.g., a registered national securities exchange or a registered national or affiliated securities association) for any act or
omission to act constituting conduct inconsistent with just and equitable principles of trade.

 

10. Governing Law;
Jurisdiction. This letter agreement shall be governed by and construed and enforced in accordance with the laws of the State
of New York, without giving effect to conflicts of law principles that would result in the application of the substantive laws
of another jurisdiction. Each of the Company and the undersigned hereby (i) agrees that any action, proceeding or claim against
him arising out of or relating in any way to this letter agreement shall be brought and enforced in the courts of the State of
New York of the United States of America for the Southern District of New York, and irrevocably submits to such jurisdiction, which
jurisdiction shall be exclusive and (ii) waives any objection to such exclusive jurisdiction and that such courts represent an
inconvenient forum.

 

11. Entire Agreement.
This letter agreement constitutes the entire agreement and understanding of the parties hereto in respect of the subject matter
hereof and supersedes all prior understandings, agreements, or representations by or among the parties hereto, written or oral,
to the extent they relate in any way to the subject matter hereof or the transactions contemplated hereby; provided, however, that
nothing herein shall be deemed to supersede or amend any of the terms of the subscription agreements between the Company and Sponsor
(and its permitted transferees) with respect to the Private Placement Warrants or Founder Shares. This letter agreement may not
be changed, amended, modified or waived except by a written instrument executed by all parties hereto.

 

12. Reliance; Specific
Enforcement.

 

(a) The undersigned acknowledges
and understands that the Underwriters and the Company will rely upon the agreements, representations and warranties set forth herein
in proceeding with the IPO. Nothing contained herein shall be deemed to render the Underwriters a representative of, or a fiduciary
with respect to, the Company, its stockholders or any creditor or vendor of the Company with respect to the subject matter hereof.

 

(b) The
undersigned hereby agrees and acknowledges that (i) each of the Underwriters and the Company may be irreparably injured in the
event of a breach of any of the obligations contained in this letter, (ii) monetary damages may not be an adequate remedy for such
breach and (iii) the non-breaching party shall be entitled to injunctive relief, in addition to any other remedy that such party
may have in law or in equity, in the event of such breach.

 

[Signature Page Follows]

 

    7

     

    

 

	 	[_____]
	 	Print Name of Insider
	 	 
	 	 
	 	Signature
	 	 
	 	Acknowledged and Agreed:
	 	 
	 	NORTHERN GENESIS ACQUISITION CORP. II
	 	 
	 	By:	 
	 	 	Name: 
	 	 	Title: 

 

 

8

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00318-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00318-of-00352.parquet"}]]